Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Silence Therapeutics PLC Sponsored ADR (SLN) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$0.56M |
|
$-88.61M |
|
$0.21M |
|
$0.34M |
|
$91.64M |
|
$-91.08M |
|
$2.48M |
|
$-88.60M |
|
$-88.60M |
|
$-88.61M |
|
$-88.61M |
|
$-88.61M |
|
$-88.61M |
|
$-91.08M |
|
$-90.52M |
|
47.23M |
|
47.23M |
|
$-1.88 |
|
$-1.88 |
|
| Balance Sheet Financials | |
$118.66M |
|
$1.58M |
|
$12.78M |
|
$131.44M |
|
$13.61M |
|
-- |
|
$55.52M |
|
$69.14M |
|
$62.30M |
|
$51.40M |
|
$62.30M |
|
47.23M |
|
| Cash Flow Statement Financials | |
$-62.27M |
|
$-47.99M |
|
$0.01M |
|
$121.33M |
|
$11.28M |
|
$-110.05M |
|
$8.07M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.72 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
61.54% |
|
-16292.84% |
|
-16292.84% |
|
-16193.56% |
|
-15849.91% |
|
-15851.88% |
|
$-62.33M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.03 |
|
0.01M |
|
-142.23% |
|
-172.41% |
|
-67.42% |
|
-142.23% |
|
$1.32 |
|
$-1.32 |
|
$-1.32 |
|